Table 4

Cardiac MRI findings

All participantsNo cardiotoxicityCardiotoxicityP valueReference ranges25 27 28
N=40N=30N=10
LV ejection fraction (%)55.2 (51.3–61.2)58.5 (54.5–61.6)49.2 (45.5–49.9) <0.001 51–70
LV end-diastolic volume, indexed to BSA (mL/m2)69.8 (62.9–82.1)66.7 (60.5–80.2)80.6 (68.6–91.1) 0.034 54–94
LV end-systolic volume, indexed to BSA (mL/m2)30.3 (25.4–37.4)28.9 (23.3–34.9)40.9 (34.8–49.6) <0.001 19–40
LV myocardial mass, indexed to BSA (g/m2)38.6 (35.9–44.2)38.5 (36.0–41.6)44.6 (35.8–50.3)0.2229–55
RV ejection fraction (%)57.7 (53.2–62.9)59.6 (54.7–63.7)54.9 (51.1–57.6)0.06147–68
RV end-diastolic volume, indexed to BSA (mL/m2)65.0 (56.8–72.2)64.3 (56.4–72.0)66.3 (59.7–77.9)0.3353–99
RV end-systolic volume, indexed to BSA26.7 (22.8–32.0)25.5 (21.3–31.6)30.4 (28.1–33.0)0.05317–46
LV global circumferential strain by FT (%)−18.8 (−20.7 to −17.6)−19.3 (−21.1 to −18.4)−17.2 (−17.9 to −15.3) 0.002 −24 to −13
LV global longitudinal strain by FT (%)−16.0 (−17.1 to −13.7)−16.2 (−17.2 to −14.8)−13.7 (−16.4 to −11.8) 0.049 −27 to −11
LV global circumferential strain by DENSE (%)−18.1 (−20.0 to −17.1)−18.2 (−20.4 to −17.2)−17.5 (−18.1 to −15.3)0.065−24 to −12
LV global longitudinal strain by DENSE (%)−7.3 (−9.5 to −5.0)−8.3 (−9.5 to −5.6)−5.3 (−7.8 to −3.0) 0.034 −19 to −11
LV global T1 (ms)1205.1 (1174.7–1222.5)1209.2 (1180.1–1223.6)1200.4 (1167.3–1208.9)0.181107–1234
Global ECV (%)27.1 (25.8–28.3)27.6 (26.5–28.6)26.9 (18.7–27.5)0.17>27.4
LV global T2 (ms)40.7 (39.3–42.5)41.1 (39.3–42.5)39.5 (38.9–42.0)0.4235–44
  • Data are presented as median+IQR.

  • Bold values are statistically signficant.

  • BSA, body surface area; DENSE, displacement encoding with stimulated echoes; ECV, extracellular volume; FT, feature tracking; LV, left ventricular; RV, right ventricular.